WO2023280313A1 - Method for purifying ursodeoxycholic acid - Google Patents
Method for purifying ursodeoxycholic acid Download PDFInfo
- Publication number
- WO2023280313A1 WO2023280313A1 PCT/CN2022/104683 CN2022104683W WO2023280313A1 WO 2023280313 A1 WO2023280313 A1 WO 2023280313A1 CN 2022104683 W CN2022104683 W CN 2022104683W WO 2023280313 A1 WO2023280313 A1 WO 2023280313A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ursodeoxycholic acid
- acid
- ursodeoxycholic
- solvent
- stir
- Prior art date
Links
- RUDATBOHQWOJDD-UHFFFAOYSA-N (3beta,5beta,7alpha)-3,7-Dihydroxycholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 RUDATBOHQWOJDD-UHFFFAOYSA-N 0.000 title claims abstract description 158
- 229960001661 ursodiol Drugs 0.000 title claims abstract description 150
- RUDATBOHQWOJDD-UZVSRGJWSA-N ursodeoxycholic acid Chemical compound C([C@H]1C[C@@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-UZVSRGJWSA-N 0.000 title claims abstract description 143
- 238000000034 method Methods 0.000 title claims abstract description 34
- 239000002904 solvent Substances 0.000 claims abstract description 23
- 238000002360 preparation method Methods 0.000 claims abstract description 4
- 230000007062 hydrolysis Effects 0.000 claims abstract description 3
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 66
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims description 49
- 238000003756 stirring Methods 0.000 claims description 42
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 36
- 238000000746 purification Methods 0.000 claims description 32
- 239000012065 filter cake Substances 0.000 claims description 31
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 24
- 238000006243 chemical reaction Methods 0.000 claims description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- 239000011259 mixed solution Substances 0.000 claims description 17
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 16
- 150000003863 ammonium salts Chemical class 0.000 claims description 13
- 239000000047 product Substances 0.000 claims description 13
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-Lutidine Substances CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 claims description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 11
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 claims description 9
- 238000010992 reflux Methods 0.000 claims description 8
- 239000012043 crude product Substances 0.000 claims description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 6
- 239000003513 alkali Substances 0.000 claims description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 229960000549 4-dimethylaminophenol Drugs 0.000 claims 1
- 125000001612 ursodeoxycholic acid group Chemical group 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 3
- 238000009776 industrial production Methods 0.000 abstract description 2
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 22
- 239000000243 solution Substances 0.000 description 20
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 16
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 12
- -1 ammonium ursodeoxycholic acid Salt Chemical class 0.000 description 11
- 239000007864 aqueous solution Substances 0.000 description 9
- 239000007791 liquid phase Substances 0.000 description 9
- RUDATBOHQWOJDD-BSWAIDMHSA-N chenodeoxycholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-BSWAIDMHSA-N 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 7
- 229960001091 chenodeoxycholic acid Drugs 0.000 description 6
- 229960003964 deoxycholic acid Drugs 0.000 description 5
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 5
- 229960000583 acetic acid Drugs 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 239000004380 Cholic acid Substances 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical group CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 3
- 210000000941 bile Anatomy 0.000 description 3
- 239000012295 chemical reaction liquid Substances 0.000 description 3
- 229960002471 cholic acid Drugs 0.000 description 3
- 238000004042 decolorization Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000012362 glacial acetic acid Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 2
- 208000008439 Biliary Liver Cirrhosis Diseases 0.000 description 2
- 208000033222 Biliary cirrhosis primary Diseases 0.000 description 2
- 208000012654 Primary biliary cholangitis Diseases 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 2
- 235000019416 cholic acid Nutrition 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- DXOCDBGWDZAYRQ-UHFFFAOYSA-N (3alpha,5beta)-3-Hydroxy-7-oxocholan-24 -oic acid Natural products C1CC(O)CC2CC(=O)C3C4CCC(C(CCC(O)=O)C)C4(C)CCC3C21C DXOCDBGWDZAYRQ-UHFFFAOYSA-N 0.000 description 1
- UYVVLXVBEQAATF-UHFFFAOYSA-N 4-(1,3,7,12-tetrahydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl)pentanoic acid Chemical compound OC1CC2CC(O)CC(O)C2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 UYVVLXVBEQAATF-UHFFFAOYSA-N 0.000 description 1
- DXOCDBGWDZAYRQ-AURDAFMXSA-N 7-oxolithocholic acid Chemical compound C1C[C@@H](O)C[C@H]2CC(=O)[C@H]3[C@@H]4CC[C@H]([C@@H](CCC(O)=O)C)[C@@]4(C)CC[C@@H]3[C@]21C DXOCDBGWDZAYRQ-AURDAFMXSA-N 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- DLGYNVMUCSTYDQ-UHFFFAOYSA-N azane;pyridine Chemical compound N.C1=CC=NC=C1 DLGYNVMUCSTYDQ-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000012450 pharmaceutical intermediate Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000011027 product recovery Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Definitions
- the invention relates to the field of separation of pharmaceutical intermediates, in particular to a method for purifying ursodeoxycholic acid.
- Ursodeoxycholic acid (Ursodeoxycholic acid, UDCA) (as shown in formula 1), chemical name 3 ⁇ , 7 ⁇ -dihydroxy-5 ⁇ -cholestane-24-acid (3 ⁇ , 7 ⁇ -dihydroxy-5 ⁇ -cholan-24- oic acid), CAS No. 128-13-2, molecular formula C 24 H 40 O 4 , molecular weight 392.56, white powder, odorless, bitter taste, melting point 203-204°C.
- Ursodeoxycholic acid is the main ingredient contained in the precious traditional Chinese medicine bear bile. It is the first-line treatment drug for primary biliary cirrhosis (PBC) approved by the US FDA. It can also effectively treat gallstone diseases and chronic liver diseases in clinical practice.
- PBC primary biliary cirrhosis
- chenodeoxycholic acid is mainly used as raw material in industry, through chemical oxidation and reduction reactions (Bioorganic & Medicinal Chemistry, 2016, 24:3986-3993. etc.) or enzymatic oxidation and reduction Reaction (Bioprocess and Biosystems Engineering, 2019, 42(9):1537-1545. etc.) to prepare ursodeoxycholic acid.
- the industry mainly uses solvents such as ethyl acetate to wash and purify for many times, and selectively dissolve and remove chenodeoxycholic acid and other related impurities from the mixture containing ursodeoxycholic acid.
- solvents such as ethyl acetate
- more than 30 times of ethyl acetate is required. Only esters can dissolve and remove impurities such as chenodeoxycholic acid, the solvent consumption is large, the cost is high, and the purification effect is not ideal.
- Chinese patent literature (CN106928306A) discloses that crude ursodeoxycholic acid is treated with triethylamine, and after three steps of refining, refined ursodeoxycholic acid is obtained, the product recovery rate is 82.8%-85.3%, the operation is relatively complicated, and the yield Not ideal either.
- the purpose of the present invention is to address the above existing problems and deficiencies, and provide a purification method that is easy to operate, uses solvents and reagents that are cheap and easy to obtain, obtains ursodeoxycholic acid with high purity, and is suitable for industrial production.
- the present invention provides a method for purifying ursodeoxycholic acid, which is characterized in that it comprises the following steps:
- step A
- the purity of the crude ursodeoxycholic acid is 70%-90%; preferably, 90%.
- the first solvent is acetone.
- the second solvent is selected from one or more of tetrahydrofuran, methanol, ethanol, etc.; preferably, the second solvent is methanol.
- the volume (ml) of the first solvent added is 4-8 times the weight (grams) of the crude ursodeoxycholic acid; preferably, it is 6 times.
- the volume (ml) of the second solvent added is 0.3-1 times the weight (grams) of the crude ursodeoxycholic acid; preferably, it is 0.5 times.
- the added amount of the 4-dimethylaminopyridine is 0.31-0.47 times of the weight of the crude product of ursodeoxycholic acid; preferably, the weight of the 4-dimethylaminopyridine is 0.32 times of the crude product of ursodeoxycholic acid. times.
- the volume (mL) of the first solvent for washing the filter cake is 1-3 times the weight (g) of the crude ursodeoxycholic acid; preferably, 1 time.
- the temperature of the temperature-rising reflux reaction is 55-70°C; preferably, 65°C.
- the time for the temperature-raising reflux reaction is preferably 2 hours.
- step B
- the volume (ml) of water used for suspending the 4-dimethylaminopyridinium salt of ursodeoxycholic acid is 5-20 times the weight (grams) of the crude ursodeoxycholic acid; preferably, it is 15 times.
- the alkali is one or more of sodium hydroxide, potassium hydroxide, lithium hydroxide, etc.; preferably, it is sodium hydroxide.
- the acid is one or more of hydrochloric acid, sulfuric acid, phosphoric acid, acetic acid, etc.; preferably, it is hydrochloric acid.
- the concentration of the base is 1-8 mol/L; preferably, 2 mol/L.
- the volume fraction of the acid is 10%-90%; preferably, 10%.
- the volume (ml) of water used for washing the filter cake is 1-5 times the weight (grams) of ursodeoxycholic acid; preferably, it is 2 times.
- base is added to adjust the pH to 12.0.
- acid is added to adjust the pH to 2.0.
- the beneficial effects of the present invention include: the purification method of ursodeoxycholic acid of the present invention, the solvent used is easy to obtain, the operation is simple, only two purification steps are used, the purity of the refined ursodeoxycholic acid is greater than 99%, and the energy consumption is less. It is convenient for industrialized production.
- step (1) dissolving the mixture containing ursodeoxycholic acid in tetrahydrofuran, adding diisopropylethylamine to react to obtain a solution containing ursodeoxycholic acid diisopropylethylammonium salt; (2) Cool the solution of ursodeoxycholic acid diisopropylethylammonium salt obtained in step (1) at 0-5° C.
- the crude product of ursodeoxycholic acid of 10g 90% purity is dissolved in the mixed solution of acetone (60mL) and methanol (5mL), is stirred and is warming up to 60 °C, adds diisopropylethylamine (3.64g), and at 65 React at °C for 2 hours, then cool the reaction solution, and stir at 0-5°C for 1 hour, no ursodeoxycholic acid diisopropylethylammonium salt crystals were observed, and finally the ursodeoxycholic acid product could not be purified .
- the diisopropylethylamine used in the patent document CN 110669091A is also a kind of organic base, it is not suitable for the purification method of the present invention, and the organic base 4-dimethylaminopyridine used in the present invention is obtained by this method.
- the inventor obtained it through multiple tests and screenings, and it is used for the purification of crude ursodeoxycholic acid, and the effect is excellent. Comparative example three
- the present invention repeats the method disclosed in the patent document CN 106928306A to purify ursodeoxycholic acid. As a result, it is found that the purification yield of ursodeoxycholic acid product is far lower than that of the examples of the present invention.
- the specific operation steps are as follows:
- the 4-dimethylaminopyridine used in the present invention is replaced by the triethylamine used in the patent document CN 106928306A, other steps are the same as the examples of the present invention, and it is found that the purification yield of the ursodeoxycholic acid product is far lower than that of the present invention the embodiment.
- the specific operation steps are as follows:
- the present invention treats crude ursodeoxycholic acid by 4-dimethylaminopyridine, not only the operation method is simple, but also the purification yield of ursodeoxycholic acid can reach up to 97.1%, and the product has high purity (liquid phase purity>99%). Therefore, the purification method of ursodeoxycholic acid described in the present invention is more efficient, simpler and more industrially valuable.
- the key technology of the present invention that can realize high-efficiency purification of ursodeoxycholic acid is to select 4-dimethylaminopyridine as the base in a specific solvent, and obtain 4-dimethylpyridinium ammonium salt of ursodeoxycholic acid in high yield , and then undergo acid hydrolysis to obtain pure ursodeoxycholic acid in high yield.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Abstract
Disclosed is a method for purifying ursodeoxycholic acid (UDCA), comprising the following steps: step A sets forth the preparation of 4-dimethylpyridine ammonium salt of UDCA; and step B sets forth the hydrolysis of the 4-dimethylpyridine ammonium salt of UDCA. In the present invention, operation is simple, solvents and reagents used are low in cost and readily available, the present invention is suitable for industrial production, and the purity of the obtained UDCA is high.
Description
本发明涉及医药中间体分离领域,具体地涉及一种熊去氧胆酸的纯化方法。The invention relates to the field of separation of pharmaceutical intermediates, in particular to a method for purifying ursodeoxycholic acid.
熊去氧胆酸(Ursodeoxycholic acid,UDCA)(如式1所示),化学名称3α,7β-二羟基-5β-胆甾烷-24-酸(3α,7β-dihydroxy-5β-cholan-24-oic acid),CAS号128-13-2,分子式C
24H
40O
4,分子量392.56,白色粉末,无臭,味苦,熔点为203-204℃。熊去氧胆酸是名贵中药熊胆所含的主要成分,是美国FDA批准的原发性胆汁性肝硬化(PBC)的一线治疗药物,在临床上还可以有效治疗胆结石类疾病和慢性肝病,具有广阔的市场前景。目前,制备熊去氧胆酸主要有动物胆汁提取和人工合成两种方法,但动物胆汁提取来源有限,难以满足临床需要,因此主要依赖人工合成。
Ursodeoxycholic acid (Ursodeoxycholic acid, UDCA) (as shown in formula 1), chemical name 3α, 7β-dihydroxy-5β-cholestane-24-acid (3α, 7β-dihydroxy-5β-cholan-24- oic acid), CAS No. 128-13-2, molecular formula C 24 H 40 O 4 , molecular weight 392.56, white powder, odorless, bitter taste, melting point 203-204°C. Ursodeoxycholic acid is the main ingredient contained in the precious traditional Chinese medicine bear bile. It is the first-line treatment drug for primary biliary cirrhosis (PBC) approved by the US FDA. It can also effectively treat gallstone diseases and chronic liver diseases in clinical practice. , has broad market prospects. At present, there are mainly two methods for the preparation of ursodeoxycholic acid: animal bile extraction and artificial synthesis. However, the source of animal bile extraction is limited and it is difficult to meet clinical needs, so it mainly relies on artificial synthesis.
目前,由于鹅去氧胆酸廉价易得,工业上主要以鹅去氧胆酸为原料,通过化学氧化、还原反应(Bioorganic&Medicinal Chemistry,2016,24:3986-3993.等)或酶法氧化、还原反应(Bioprocess andBiosystems Engineering,2019,42(9):1537-1545.等)来制备熊去氧胆酸。在此反应产物中,除产品熊去氧胆酸,还有中间体7-酮石胆酸(7K-LCA,3α-羟基-7-羰基-5β-胆烷酸)以及鹅去氧胆酸(Chenodeoxycholic acid,CDCA,3α,7α-二羟基-5β-胆烷-24-酸)等副产物,纯化较为困难。At present, because chenodeoxycholic acid is cheap and easy to obtain, chenodeoxycholic acid is mainly used as raw material in industry, through chemical oxidation and reduction reactions (Bioorganic & Medicinal Chemistry, 2016, 24:3986-3993. etc.) or enzymatic oxidation and reduction Reaction (Bioprocess and Biosystems Engineering, 2019, 42(9):1537-1545. etc.) to prepare ursodeoxycholic acid. In this reaction product, in addition to the product ursodeoxycholic acid, there are intermediates 7-ketolithocholic acid (7K-LCA, 3α-hydroxy-7-carbonyl-5β-cholic acid) and chenodeoxycholic acid ( Chenodeoxycholic acid, CDCA, 3α, 7α-dihydroxy-5β-cholan-24-acid) and other by-products, purification is more difficult.
目前工业上主要采用乙酸乙酯等溶剂多次洗涤纯化,选择性地从含有熊去氧胆酸的混合物中溶解除去鹅去氧胆酸等相关杂质,实际生产中需要用30倍以上的乙酸乙酯才能将鹅去氧胆酸等杂质溶解除去,溶剂消耗大、成本高,纯化效果不理想。中国专利文献(CN106928306A)公开了通过三乙胺处理粗品熊去氧胆酸,经过三步精制步骤,得到熊去氧胆酸精品,产品回收率82.8%-85.3%,操作相对较复杂,收率也不理想。At present, the industry mainly uses solvents such as ethyl acetate to wash and purify for many times, and selectively dissolve and remove chenodeoxycholic acid and other related impurities from the mixture containing ursodeoxycholic acid. In actual production, more than 30 times of ethyl acetate is required. Only esters can dissolve and remove impurities such as chenodeoxycholic acid, the solvent consumption is large, the cost is high, and the purification effect is not ideal. Chinese patent literature (CN106928306A) discloses that crude ursodeoxycholic acid is treated with triethylamine, and after three steps of refining, refined ursodeoxycholic acid is obtained, the product recovery rate is 82.8%-85.3%, the operation is relatively complicated, and the yield Not ideal either.
发明内容Contents of the invention
本发明的目的是针对以上存在的问题与不足,提供一种操作简便、使用的溶剂、试剂价廉易得、得到的熊去氧胆酸纯度高、适宜工业化生产的纯化方法。The purpose of the present invention is to address the above existing problems and deficiencies, and provide a purification method that is easy to operate, uses solvents and reagents that are cheap and easy to obtain, obtains ursodeoxycholic acid with high purity, and is suitable for industrial production.
为了实现上述目的,本发明提供了一种纯化熊去氧胆酸的方法,其特点是,包括以下步骤:In order to achieve the above object, the present invention provides a method for purifying ursodeoxycholic acid, which is characterized in that it comprises the following steps:
A.熊去氧胆酸的4-二甲基吡啶铵盐的制备A. Preparation of 4-lutidine ammonium salt of ursodeoxycholic acid
将熊去氧胆酸粗品溶于第一溶剂和第二溶剂的混合溶液中,搅拌升温至55-70℃,加入4-二甲氨基吡啶(DMAP),升温回流反应1-4h,缓慢降温,在0-5℃条件下搅拌0.5-4h,抽滤,用第一溶剂洗涤滤饼,干燥,得到熊去氧胆酸的4-二甲基吡啶铵盐。Dissolve the crude ursodeoxycholic acid in the mixed solution of the first solvent and the second solvent, stir and heat up to 55-70°C, add 4-dimethylaminopyridine (DMAP), heat up and reflux for 1-4h, and slowly cool down, Stir at 0-5°C for 0.5-4h, filter with suction, wash the filter cake with the first solvent, and dry to obtain 4-dimethylpyridinium ammonium salt of ursodeoxycholic acid.
B.熊去氧胆酸的4-二甲基吡啶铵盐的水解B. Hydrolysis of 4-lutidinium salt of ursodeoxycholic acid
将步骤A中得到的熊去氧胆酸的4-二甲基吡啶铵盐悬浮在水中,加入碱,调节pH调节至12.0-12.5,在20-25℃条件下搅拌1-4h;滴加酸调节pH至2.0-2.5,在20-25℃搅拌1-4h;过滤,收集滤饼并用水洗涤,干燥,得到熊去氧胆酸纯品。Suspend the 4-lutidine ammonium salt of ursodeoxycholic acid obtained in step A in water, add alkali, adjust the pH to 12.0-12.5, stir at 20-25°C for 1-4h; add acid dropwise Adjust the pH to 2.0-2.5, stir at 20-25°C for 1-4h; filter, collect the filter cake, wash with water, and dry to obtain pure ursodeoxycholic acid.
所述反应过程如路线(I)所示:Described reaction process is as shown in route (I):
路线(I)Route (I)
步骤A中,In step A,
所述熊去氧胆酸粗品的纯度为70%-90%;优选地,为90%。The purity of the crude ursodeoxycholic acid is 70%-90%; preferably, 90%.
所述第一溶剂为丙酮。The first solvent is acetone.
所述第二溶剂选自四氢呋喃、甲醇、乙醇等中的一种或多种;优选地,所述第二溶剂为甲醇。The second solvent is selected from one or more of tetrahydrofuran, methanol, ethanol, etc.; preferably, the second solvent is methanol.
所述加入的第一溶剂体积(毫升)数是熊去氧胆酸粗品重量(克)数的4-8倍;优选地,为6倍。The volume (ml) of the first solvent added is 4-8 times the weight (grams) of the crude ursodeoxycholic acid; preferably, it is 6 times.
所述加入的第二溶剂体积(毫升)数是熊去氧胆酸粗品重量(克)数的0.3-1倍;优选地,为0.5倍。The volume (ml) of the second solvent added is 0.3-1 times the weight (grams) of the crude ursodeoxycholic acid; preferably, it is 0.5 times.
所述4-二甲氨基吡啶的加入量是所述熊去氧胆酸粗品重量的0.31-0.47倍;优选地,所述4-二甲氨基吡啶的重量是熊去氧胆酸粗品重量的0.32倍。The added amount of the 4-dimethylaminopyridine is 0.31-0.47 times of the weight of the crude product of ursodeoxycholic acid; preferably, the weight of the 4-dimethylaminopyridine is 0.32 times of the crude product of ursodeoxycholic acid. times.
所述洗涤滤饼的第一溶剂的体积(毫升)数是熊去氧胆酸粗品重量(克)数的1-3倍倍;优选地,为1倍。The volume (mL) of the first solvent for washing the filter cake is 1-3 times the weight (g) of the crude ursodeoxycholic acid; preferably, 1 time.
所述升温回流反应的温度为55-70℃;优选地,为65℃。The temperature of the temperature-rising reflux reaction is 55-70°C; preferably, 65°C.
所述升温回流反应的时间优选为2h。The time for the temperature-raising reflux reaction is preferably 2 hours.
在0-5℃条件下优选搅拌1h。Stir preferably for 1 h at 0-5 °C.
步骤B中,In step B,
所述熊去氧胆酸的4-二甲氨基吡啶铵盐悬浮使用的水体积(毫升)数是熊去氧胆酸粗品重量(克)数的5-20倍;优选地,为15倍。The volume (ml) of water used for suspending the 4-dimethylaminopyridinium salt of ursodeoxycholic acid is 5-20 times the weight (grams) of the crude ursodeoxycholic acid; preferably, it is 15 times.
所述碱为氢氧化钠、氢氧化钾、氢氧化锂等中的一种或几种;优选地,为氢氧化钠。The alkali is one or more of sodium hydroxide, potassium hydroxide, lithium hydroxide, etc.; preferably, it is sodium hydroxide.
所述酸为盐酸、硫酸、磷酸、乙酸等中的一种或几种;优选地,为盐酸。The acid is one or more of hydrochloric acid, sulfuric acid, phosphoric acid, acetic acid, etc.; preferably, it is hydrochloric acid.
所述碱的浓度为1-8mol/L;优选地,为2mol/L。The concentration of the base is 1-8 mol/L; preferably, 2 mol/L.
所述酸的体积分数为10%-90%;优选地,为10%。The volume fraction of the acid is 10%-90%; preferably, 10%.
所述洗涤滤饼所用水的体积(毫升)数是熊去氧胆酸重量(克)数的1-5倍;优选地,为2倍。The volume (ml) of water used for washing the filter cake is 1-5 times the weight (grams) of ursodeoxycholic acid; preferably, it is 2 times.
优选地,加入碱调节pH至12.0。Preferably, base is added to adjust the pH to 12.0.
优选地,加入酸调节pH至2.0。Preferably, acid is added to adjust the pH to 2.0.
本发明在加入碱或者加入酸调节pH后,优选在20-25℃搅拌1h。In the present invention, after adding alkali or adding acid to adjust the pH, it is preferably stirred at 20-25° C. for 1 h.
本发明的有益效果包括,本发明熊去氧胆酸的纯化方法,所用溶剂易得,操作简单,只用两步纯化步骤,精制得到的熊去氧胆酸纯度大于99%,耗能少,便于工业化生产。The beneficial effects of the present invention include: the purification method of ursodeoxycholic acid of the present invention, the solvent used is easy to obtain, the operation is simple, only two purification steps are used, the purity of the refined ursodeoxycholic acid is greater than 99%, and the energy consumption is less. It is convenient for industrialized production.
结合以下具体实施例,对本发明作进一步详细说明,实施本发明的过程、条件、试剂、实验方法等,除以下专门提及的内容之外,均为本领域的普遍知识和公知常识,本发明没有特别限制内容。In conjunction with the following specific examples, the present invention will be further described in detail, and the process, conditions, reagents, experimental methods, etc. of implementing the present invention, except for the content specifically mentioned below, are general knowledge and common knowledge in the art, the present invention Contents are not particularly limited.
实施例一Embodiment one
将10g 90%纯度的熊去氧胆酸粗品溶解于丙酮(60mL)和甲醇(5mL)的混合溶液中,搅拌升温至60℃,加入4-二甲氨基吡啶(3.2g),并在65℃下反应2h,然后将反应液冷却,在0-5℃下搅拌1h,抽滤,滤饼用丙酮(10mL)洗涤,真空干燥,得到熊去氧胆酸的4-二甲基吡啶铵盐(11.6g)。Dissolve 10 g of crude ursodeoxycholic acid with 90% purity in a mixed solution of acetone (60 mL) and methanol (5 mL), stir and heat up to 60 ° C, add 4-dimethylaminopyridine (3.2 g), and The reaction solution was reacted for 2 hours, then the reaction liquid was cooled, stirred at 0-5° C. for 1 hour, suction filtered, the filter cake was washed with acetone (10 mL), and dried in vacuo to obtain 4-lutidine ammonium salt of ursodeoxycholic acid ( 11.6g).
上述熊去氧胆酸的4-二甲基吡啶铵盐悬浮在水中(150mL),加入2mol/L的氢氧化钠水溶液,将pH调节至12.0,在20-25℃下搅拌1h;滴加10%的稀盐酸调节pH至2.0,在20-25℃搅拌1h;过滤,收集滤饼并用水(200mL)洗涤,真空干燥,得到熊去氧胆酸8.74g(液相纯度>99%),熊去氧胆酸纯化收率97.1%。Suspend the 4-dimethylpyridinium ammonium salt of ursodeoxycholic acid in water (150 mL), add 2 mol/L sodium hydroxide aqueous solution, adjust the pH to 12.0, stir at 20-25 °C for 1 h; add dropwise 10 % dilute hydrochloric acid to adjust the pH to 2.0, and stirred at 20-25°C for 1h; filtered, collected the filter cake and washed with water (200mL), and dried in vacuo to obtain 8.74g of ursodeoxycholic acid (liquid phase purity>99%), bear The purification yield of deoxycholic acid was 97.1%.
实施例二Embodiment two
将10g 80%纯度的熊去氧胆酸粗品溶解于丙酮(60mL)和甲醇(5mL)的混合溶液中,搅拌升温至60℃,加入4-二甲氨基吡啶(3.2g),并在65℃下反应1.5h,然后将反应液冷却,在0-5℃下搅拌1h,抽滤,滤饼用丙酮(10mL)洗涤,真空干燥,得到熊去氧胆酸的4-二甲基吡啶铵盐(10g)。Dissolve 10 g of crude ursodeoxycholic acid with 80% purity in a mixed solution of acetone (60 mL) and methanol (5 mL), stir and heat up to 60° C., add 4-dimethylaminopyridine (3.2 g), and The reaction mixture was reacted at low temperature for 1.5h, then the reaction solution was cooled, stirred at 0-5°C for 1h, filtered with suction, the filter cake was washed with acetone (10mL), and dried in vacuo to obtain 4-dimethylpyridinium ammonium salt of ursodeoxycholic acid (10g).
上述熊去氧胆酸的4-二甲基吡啶铵盐悬浮在水中(150mL),加入4mol/L的氢氧化钠水溶液,将pH调节至12.0,在20-25℃下搅拌1h;滴加10%的稀盐酸调节pH至2.0,在20-25℃搅拌1h;过滤,收集滤饼并用水(200mL)洗涤,真空干燥,得到熊去氧胆酸7.65g(液相纯度>99%),熊去氧胆酸纯化收率95.6%。Suspend the 4-dimethylpyridinium ammonium salt of ursodeoxycholic acid in water (150 mL), add 4 mol/L sodium hydroxide aqueous solution, adjust the pH to 12.0, stir at 20-25 °C for 1 h; add dropwise 10 % dilute hydrochloric acid to adjust the pH to 2.0, and stirred at 20-25°C for 1h; filtered, collected the filter cake and washed with water (200mL), and dried in vacuo to obtain 7.65g of ursodeoxycholic acid (liquid phase purity>99%), bear The purification yield of deoxycholic acid was 95.6%.
实施例三Embodiment Three
将10g 85%纯度的熊去氧胆酸粗品溶解于丙酮(60mL)和乙醇(5mL)的混合溶液中,搅拌升温至60℃,加入4-二甲氨基吡啶(3.2g),并在65℃下反应2h,然后将反应液冷却,在0-5℃下搅拌2h,抽滤,滤饼用丙酮(10mL)洗涤,真空干燥,得到熊去氧胆酸的4-二甲基吡啶铵盐(10.7g)。Dissolve 10 g of 85% pure ursodeoxycholic acid in a mixed solution of acetone (60 mL) and ethanol (5 mL), stir and heat up to 60 ° C, add 4-dimethylaminopyridine (3.2 g), and The reaction solution was reacted for 2 hours, then the reaction solution was cooled, stirred at 0-5°C for 2 hours, suction filtered, the filter cake was washed with acetone (10 mL), and dried in vacuo to obtain 4-lutidine ammonium salt of ursodeoxycholic acid ( 10.7g).
上述熊去氧胆酸的4-二甲基吡啶铵盐悬浮在水中(150mL),加入2mol/L的氢氧化钠水溶液,将pH调节至12.5,在20-25℃下搅拌1h;滴加10%的稀盐酸调节pH至2.5,在20-25℃搅拌1h;过滤,收集滤饼并用水(300mL)洗涤,真空干燥,得到熊去氧胆酸纯品8.07g(液相纯度>99%),熊去氧胆酸纯化收率95%。Suspend the 4-dimethylpyridinium ammonium salt of ursodeoxycholic acid in water (150 mL), add 2 mol/L sodium hydroxide aqueous solution, adjust the pH to 12.5, stir at 20-25 °C for 1 h; add dropwise 10 % dilute hydrochloric acid to adjust the pH to 2.5, and stirred at 20-25°C for 1h; filtered, collected the filter cake and washed with water (300mL), and dried in vacuo to obtain 8.07g of pure ursodeoxycholic acid (liquid phase purity>99%) , The purification yield of ursodeoxycholic acid was 95%.
实施例四Embodiment Four
将10g 90%纯度的熊去氧胆酸粗品溶解于丙酮(60mL)和四氢呋喃(5mL)的混合溶液中,搅拌升温至60℃,加入4-二甲氨基吡啶(3.2g),并在70℃下反应2h,然后将反应液冷却,在0-5℃下搅拌2h,抽滤,滤饼用丙酮(10mL)冲洗滤饼,真空干燥,得到熊去氧胆酸的4-二甲基吡啶铵盐(11.4g)。Dissolve 10 g of crude ursodeoxycholic acid with 90% purity in a mixed solution of acetone (60 mL) and tetrahydrofuran (5 mL), stir and heat up to 60 ° C, add 4-dimethylaminopyridine (3.2 g), and The reaction solution was reacted for 2 hours, then the reaction solution was cooled, stirred at 0-5°C for 2 hours, filtered with suction, the filter cake was rinsed with acetone (10 mL), and dried in vacuo to obtain 4-dimethylpyridinium ammonium ursodeoxycholic acid Salt (11.4g).
上述熊去氧胆酸的4-二甲基吡啶铵盐悬浮在水中(100mL),加入4mol/L的氢氧化钠水溶液,将pH调节至12.5,在20-25℃下搅拌2h;滴加30%的稀盐酸调节pH至2.0,在20-25℃搅拌2h;过滤,收集滤饼并用水(150mL)洗涤,真空干燥,得到熊去氧胆酸纯品8.5g(液相纯度>99%),熊去氧胆酸纯化收率94.4%。Suspend the 4-dimethylpyridinium ammonium salt of ursodeoxycholic acid in water (100 mL), add 4 mol/L sodium hydroxide aqueous solution, adjust the pH to 12.5, stir at 20-25 °C for 2 h; add dropwise 30 % dilute hydrochloric acid to adjust the pH to 2.0, stir at 20-25°C for 2h; filter, collect the filter cake and wash with water (150mL), and vacuum-dry to obtain 8.5g of pure ursodeoxycholic acid (purity in liquid phase>99%) , the purification yield of ursodeoxycholic acid was 94.4%.
实施例五Embodiment five
将10g 90%纯度的熊去氧胆酸粗品溶解于丙酮(60mL)和甲醇(8mL)的混合溶液中,搅拌升温至70℃,加入4-二甲氨基吡啶(3.6g),并在65℃下反应3h,然后将反应液冷却,在0-5℃下搅拌1h,抽滤,滤饼用丙酮(20mL)洗涤,真空干燥,得到熊去氧胆酸的4-二甲基吡啶铵盐(11.3g)。Dissolve 10 g of crude ursodeoxycholic acid with 90% purity in a mixed solution of acetone (60 mL) and methanol (8 mL), stir and heat up to 70 ° C, add 4-dimethylaminopyridine (3.6 g), and The reaction solution was reacted for 3 h at lower temperature, then the reaction solution was cooled, stirred at 0-5° C. for 1 h, filtered with suction, the filter cake was washed with acetone (20 mL), and dried in vacuo to obtain 4-lutidine ammonium salt of ursodeoxycholic acid ( 11.3g).
上述熊去氧胆酸的4-二甲基吡啶铵盐悬浮在水中(200mL),加入2mol/L的氢氧化钠水溶液,将pH调节至12.0,在20-25℃下搅拌2h;滴加10%的稀盐酸调节pH至2.3,在20-25℃搅拌2h;过滤,收集滤饼并用水(400mL)洗涤,真空干燥,得到熊去氧胆酸8.58g(液相纯度>99%),熊去氧胆酸纯化收率95.3%。Suspend the 4-dimethylpyridinium ammonium salt of ursodeoxycholic acid in water (200mL), add 2mol/L sodium hydroxide aqueous solution, adjust the pH to 12.0, stir at 20-25°C for 2h; add dropwise 10 % dilute hydrochloric acid to adjust the pH to 2.3, and stirred at 20-25°C for 2h; filtered, collected the filter cake and washed with water (400mL), and dried in vacuo to obtain 8.58g of ursodeoxycholic acid (liquid phase purity>99%), bear The purification yield of deoxycholic acid was 95.3%.
实施例六Embodiment six
将10g 90%纯度的熊去氧胆酸粗品溶解于丙酮(70mL)和乙醇(6mL)的混合溶液中,搅拌升温至70℃,加入4-二甲氨基吡啶(3.2g),并在60℃下反应3h,然后将反应液冷却,在0-5℃下搅拌1h,抽滤,滤饼用丙酮(15mL)洗涤,真空干燥,得到熊去氧胆酸的4-二甲基吡啶铵盐(11.2g)。10g of crude ursodeoxycholic acid with 90% purity was dissolved in a mixed solution of acetone (70mL) and ethanol (6mL), stirred and heated to 70°C, added 4-dimethylaminopyridine (3.2g), and heated at 60°C The reaction solution was reacted for 3 h at low temperature, then the reaction solution was cooled, stirred at 0-5° C. for 1 h, filtered with suction, the filter cake was washed with acetone (15 mL), and dried in vacuo to obtain 4-lutidine ammonium salt of ursodeoxycholic acid ( 11.2g).
上述熊去氧胆酸的4-二甲基吡啶铵盐悬浮在水中(200mL),加入4mol/L的氢氧化锂水溶液,将pH调节至12.0,在20-25℃下搅拌2h;滴加10%的稀硫酸调节pH至2.5,在20-25℃搅拌2h;过滤,收集滤饼并用水(200mL)洗涤,真空干燥,得到熊去氧胆酸8.53g(液相纯度>99%),熊去氧胆酸纯化收率94.8%。Suspend the 4-dimethylpyridinium ammonium salt of ursodeoxycholic acid in water (200 mL), add 4 mol/L lithium hydroxide aqueous solution, adjust the pH to 12.0, stir at 20-25 °C for 2 h; add dropwise 10 % dilute sulfuric acid to adjust the pH to 2.5, and stirred at 20-25°C for 2h; filtered, collected the filter cake and washed with water (200mL), and dried in vacuo to obtain 8.53g of ursodeoxycholic acid (liquid phase purity>99%), bear The purification yield of deoxycholic acid was 94.8%.
实施例七Embodiment seven
将10g 88%纯度的熊去氧胆酸粗品溶解于丙酮(60mL)和乙醇(5mL)的混合溶液中,搅拌升温至55℃,加入4-二甲氨基吡啶(4.0g),并在65℃下反应2h,然后将反应液冷却,在0-5℃下搅拌2h,抽滤,滤饼用丙酮(20mL)洗涤,真空干燥,得到熊去氧胆酸的4-二甲基吡啶铵盐(11.0g)。10g of crude ursodeoxycholic acid with 88% purity was dissolved in a mixed solution of acetone (60mL) and ethanol (5mL), stirred and heated to 55°C, added 4-dimethylaminopyridine (4.0g), and heated at 65°C The reaction solution was reacted for 2 hours at low temperature, then the reaction solution was cooled, stirred at 0-5°C for 2 hours, filtered with suction, the filter cake was washed with acetone (20 mL), and dried in vacuo to obtain 4-lutidine ammonium salt of ursodeoxycholic acid ( 11.0 g).
上述熊去氧胆酸的4-二甲基吡啶铵盐悬浮在水中(150mL),加入4mol/L的氢氧化钠水溶液,将pH调节至12.0,在20-25℃下搅拌2h;滴加50%的稀盐酸调节pH至2.0,在20-25℃搅拌2h;过滤,收集滤饼并用水(100mL)洗涤,真空干燥,得到熊去氧胆酸纯品8.38g(液相纯度>99%),熊去氧胆酸纯化收率95.2%。Suspend the 4-dimethylpyridinium ammonium salt of ursodeoxycholic acid in water (150 mL), add 4 mol/L sodium hydroxide aqueous solution, adjust the pH to 12.0, stir at 20-25 ° C for 2 h; dropwise add 50 % dilute hydrochloric acid to adjust the pH to 2.0, and stir at 20-25°C for 2h; filter, collect the filter cake and wash with water (100mL), and vacuum-dry to obtain 8.38g of pure ursodeoxycholic acid (liquid phase purity>99%) , the purification yield of ursodeoxycholic acid was 95.2%.
对比例一Comparative example one
专利文献CN 110669091A的操作步骤如下:The operation steps of the patent document CN 110669091A are as follows:
(1)将含有熊去氧胆酸的混合物溶解在四氢呋喃中,加入二异丙基乙基胺进行反应,制得含有熊去氧胆酸二异丙基乙基铵盐的溶液;(2)在0-5℃下冷却步骤(1)所得熊去氧胆酸二异丙基乙基铵盐的溶液,使其结晶,分离得到熊去氧胆酸二异丙基乙基铵盐;(3)将熊去氧胆酸二异丙基乙基铵盐悬浮在超纯水中,加入氢氧化钠水溶液,将pH调节至12.0-12.5;经二氯甲烷萃取后,将水相投入反应瓶中,搅拌升温,滴加稀盐酸调节pH为2.0-2.5;将浆液冷却,过滤,收集滤饼并用超纯水洗涤,干燥,得到熊去氧胆酸纯品。(1) dissolving the mixture containing ursodeoxycholic acid in tetrahydrofuran, adding diisopropylethylamine to react to obtain a solution containing ursodeoxycholic acid diisopropylethylammonium salt; (2) Cool the solution of ursodeoxycholic acid diisopropylethylammonium salt obtained in step (1) at 0-5° C. to crystallize and separate to obtain ursodeoxycholic acid diisopropylethylammonium salt; (3 ) Suspend ursodeoxycholic acid diisopropylethylammonium salt in ultrapure water, add sodium hydroxide aqueous solution, adjust the pH to 12.0-12.5; after dichloromethane extraction, put the water phase into the reaction flask , stirring and heating up, adding dilute hydrochloric acid dropwise to adjust the pH to 2.0-2.5; cooling the slurry, filtering, collecting the filter cake, washing with ultrapure water, and drying to obtain pure ursodeoxycholic acid.
本发明用专利文献CN 110669091A公开的方法纯化熊去氧胆酸的过程中,未观测到熊去氧胆酸二异丙基乙基铵盐晶体析出,未能纯化熊去氧胆酸产品。具体操作步骤如下:In the process of purifying ursodeoxycholic acid by the method disclosed in the patent document CN 110669091A, the precipitation of ursodeoxycholic acid diisopropylethylammonium salt crystals was not observed, and the ursodeoxycholic acid product could not be purified. The specific operation steps are as follows:
将10g 90%纯度的熊去氧胆酸粗品溶解于四氢呋喃(100mL)中,搅拌升温至55℃,加入二异丙基乙基胺(3.3g),并在65℃下反应1h,然后将所得反应液冷却至0-5℃,未观测到熊去氧胆酸二异丙基乙基铵盐晶体析出,未得到熊去氧胆酸的纯品。因此,用此专利文献CN 110669091A公开的方法来纯化熊去氧胆酸可行性差。Dissolve 10 g of crude ursodeoxycholic acid with a purity of 90% in tetrahydrofuran (100 mL), stir and heat up to 55° C., add diisopropylethylamine (3.3 g), and react at 65° C. for 1 h, and then dissolve the obtained The reaction liquid was cooled to 0-5° C., no crystals of ursodeoxycholic acid diisopropylethylammonium salt were observed, and no pure ursodeoxycholic acid was obtained. Therefore, the method disclosed in this patent document CN 110669091A is not feasible to purify ursodeoxycholic acid.
对比例二Comparative example two
将本发明方法中用到的碱4-二甲氨基吡啶替换成专利文献CN 110669091A中使用的二异丙基乙基胺,其他步骤同本发明实施例,结果发现熊去氧胆酸产品的纯化收率远低于本发明的实施例。具体操作步骤如下:The base 4-dimethylaminopyridine used in the method of the present invention is replaced by diisopropylethylamine used in the patent document CN 110669091A, other steps are the same as the examples of the present invention, and it is found that the purification of ursodeoxycholic acid product The yield is much lower than the examples of the present invention. The specific operation steps are as follows:
将10g 90%纯度的熊去氧胆酸粗品溶解于丙酮(60mL)和甲醇(5mL)的混合溶液中,搅拌升温至60℃,加入二异丙基乙基胺(3.64g),并在65℃下反应2h,然后将反应液冷却,在0-5℃条件下搅拌1h,未观测到熊去氧胆酸二异丙基乙基铵盐晶体析出,最终未能纯化熊去氧胆酸产品。因此,专利文献CN 110669091A中使用的二异丙基乙基胺虽然也是一种有机碱,但不适用于本发明的纯化方法,本发明所使用的有机碱4-二甲氨基吡啶,是通过本发明人多次试验、筛选获得的,用于熊去氧胆酸粗品的纯化,效果极佳。 对比例三The crude product of ursodeoxycholic acid of 10g 90% purity is dissolved in the mixed solution of acetone (60mL) and methanol (5mL), is stirred and is warming up to 60 ℃, adds diisopropylethylamine (3.64g), and at 65 React at ℃ for 2 hours, then cool the reaction solution, and stir at 0-5℃ for 1 hour, no ursodeoxycholic acid diisopropylethylammonium salt crystals were observed, and finally the ursodeoxycholic acid product could not be purified . Therefore, although the diisopropylethylamine used in the patent document CN 110669091A is also a kind of organic base, it is not suitable for the purification method of the present invention, and the organic base 4-dimethylaminopyridine used in the present invention is obtained by this method. The inventor obtained it through multiple tests and screenings, and it is used for the purification of crude ursodeoxycholic acid, and the effect is excellent. Comparative example three
将专利文献CN 110669091A中的二异丙基乙基胺替换为本发明提到的4-二甲氨基吡啶,其他步骤同专利文献CN 110669091A,未能纯化熊去氧胆酸产品。具体操作步骤如下:The diisopropylethylamine in the patent document CN 110669091A was replaced by the 4-dimethylaminopyridine mentioned in the present invention, and the other steps were the same as the patent document CN 110669091A, but the ursodeoxycholic acid product could not be purified. The specific operation steps are as follows:
将10g 90%纯度的熊去氧胆酸粗品溶解于四氢呋喃中(100mL),搅拌升温至55℃,加入DMAP(3.2g),并在65℃下反应1h,然后将反应液冷却至0-5℃,未观测到熊去氧胆酸的4-二甲基吡啶铵盐晶体析出,最终未能纯化熊去氧胆酸产品。Dissolve 10 g of crude ursodeoxycholic acid with 90% purity in tetrahydrofuran (100 mL), stir and heat up to 55 ° C, add DMAP (3.2 g), and react at 65 ° C for 1 h, then cool the reaction solution to 0-5 ℃, no 4-dimethylpyridinium ammonium salt crystals of ursodeoxycholic acid were observed, and finally the ursodeoxycholic acid product could not be purified.
对比例四Comparative example four
专利文献CN 106928306A的操作步骤如下:The operation steps of the patent document CN 106928306A are as follows:
(1)将含有熊去氧胆酸的混合物溶解在丙酮和乙醇的混合溶液中,搅拌升温,加入三乙胺进行反应,制得含有熊去氧胆酸三乙铵盐的溶液,冷却,过滤得到熊去氧胆酸三乙铵盐;(2)将熊去氧胆酸三乙铵盐加入丙酮和水,升温溶解,加入冰乙酸调节pH至4-5,加入活性炭脱色,滤除活性炭,常压蒸馏回收丙酮,冷却反应液,过滤,干燥得到熊去氧胆酸;(3)将步骤(2)所得熊去氧胆酸再用乙酸乙酯重结晶精制,过滤,干燥得到熊去氧胆酸,熊去氧胆酸的纯化收率为82.8%-85.3%。(1) Dissolve the mixture containing ursodeoxycholic acid in a mixed solution of acetone and ethanol, stir and heat up, add triethylamine to react, and prepare a solution containing ursodeoxycholic acid triethylammonium salt, cool, filter Obtain ursodeoxycholic acid triethylammonium salt; (2) add ursodeoxycholic acid triethylammonium salt into acetone and water, heat up and dissolve, add glacial acetic acid to adjust pH to 4-5, add activated carbon for decolorization, filter out activated carbon, Atmospheric distillation recovers acetone, cools the reaction liquid, filters, and dries to obtain ursodeoxycholic acid; (3) recrystallizes and refines ursodeoxycholic acid obtained in step (2) with ethyl acetate, filters, and dries to obtain ursodeoxycholic acid The cholic acid, ursodeoxycholic acid, has a purification yield of 82.8%-85.3%.
本发明重复专利文献CN 106928306A公开的方法纯化熊去氧胆酸,结果发现熊去氧胆酸产品的纯化收率远低于本发明的实施例。具体操作步骤如下:The present invention repeats the method disclosed in the patent document CN 106928306A to purify ursodeoxycholic acid. As a result, it is found that the purification yield of ursodeoxycholic acid product is far lower than that of the examples of the present invention. The specific operation steps are as follows:
(1)将10g 80%纯度的熊去氧胆酸粗品溶解于丙酮(60mL)和乙醇(5mL)的混合溶液中,搅拌升温至46℃,维持温度1.5h,加入一倍体积的三乙胺(10mL),升温回流1.5h,降温至14℃,搅拌反应4h,过滤,用丙酮(10mL)洗涤滤饼,干燥,得到熊去氧胆酸的三乙铵盐(8.5g)。(2)上述熊去氧胆酸的三乙铵盐悬浮在水中(150mL),加入丙酮(100mL)和水(30mL),搅拌升温至46℃,维持温度0.5h,待完全溶解后,滴加冰乙酸调节PH值在4.7,加入5%质量的活性炭(0.5g)脱色2h,滤除活性炭,用丙酮(7mL)和水(3mL)的混合溶液洗涤活性炭,65℃以下常压蒸馏回收丙酮至残留液体70mL左右,停止回收,缓慢降温至10-15℃,搅拌1h,过滤,用水(10mL)洗涤滤饼,干燥得到熊去氧胆酸粗品;(3)将步骤(2)所得熊去氧胆酸加入3倍体积的乙酸 乙酯,升温回流2h,缓慢降温至0-5℃,搅拌4h,过滤,干燥,得到熊去氧胆酸6.6g,纯化收率为82.5%,此方法的熊去氧胆酸纯化收率低于本发明方法的实施例。(1) Dissolve 10g of crude ursodeoxycholic acid with 80% purity in a mixed solution of acetone (60mL) and ethanol (5mL), stir and heat up to 46°C, maintain the temperature for 1.5h, add one volume of triethylamine (10 mL), heated to reflux for 1.5 h, cooled to 14 ° C, stirred for 4 h, filtered, washed the filter cake with acetone (10 mL), and dried to obtain triethylammonium salt of ursodeoxycholic acid (8.5 g). (2) The above-mentioned triethylammonium salt of ursodeoxycholic acid is suspended in water (150mL), add acetone (100mL) and water (30mL), stir and heat up to 46°C, maintain the temperature for 0.5h, and after it is completely dissolved, add dropwise Glacial acetic acid adjusted the pH value at 4.7, added 5% mass of activated carbon (0.5g) for decolorization for 2h, filtered the activated carbon, washed the activated carbon with a mixed solution of acetone (7mL) and water (3mL), and recovered the acetone by atmospheric distillation below 65°C to The residual liquid is about 70mL, stop the recovery, slowly cool down to 10-15°C, stir for 1h, filter, wash the filter cake with water (10mL), and dry to obtain the crude ursodeoxycholic acid; (3) the ursodeoxycholic acid obtained in step (2) Add 3 times the volume of ethyl acetate to cholic acid, heat up and reflux for 2 hours, slowly cool down to 0-5°C, stir for 4 hours, filter, and dry to obtain 6.6 g of ursodeoxycholic acid, with a purification yield of 82.5%. The deoxycholic acid purification yield is lower than the embodiment of the method of the present invention.
对比例五Comparative example five
将本发明用到的4-二甲氨基吡啶替换成专利文献CN 106928306A中使用的三乙胺,其他步骤同本发明实施例,结果发现熊去氧胆酸产品的纯化收率远低于本发明的实施例。具体操作步骤如下:The 4-dimethylaminopyridine used in the present invention is replaced by the triethylamine used in the patent document CN 106928306A, other steps are the same as the examples of the present invention, and it is found that the purification yield of the ursodeoxycholic acid product is far lower than that of the present invention the embodiment. The specific operation steps are as follows:
将10g 90%纯度的熊去氧胆酸粗品溶解于丙酮(60mL)和乙醇(5mL)的混合溶液中,搅拌升温至60℃,加入三乙胺(2.84g),并在65℃下反应2h,然后将反应液冷却,在0-5℃条件下搅拌1h,抽滤,滤饼用丙酮(10mL)冲洗滤饼,真空干燥,得到熊去氧胆酸的三乙铵盐(9.5g)。上述熊去氧胆酸的三乙铵盐悬浮在水中(150mL),加入2mol/L的氢氧化钠水溶液,将pH调节至12.0,在20-25℃条件下搅拌1h;滴加10%的稀盐酸调节pH至2.0,在20-25℃搅拌1h;过滤,收集滤饼并用水洗涤,真空干燥,得到熊去氧胆酸纯品7.56g,熊去氧胆酸的纯化收率84%,此方法的熊去氧胆酸纯化收率低于本发明方法的实施例。Dissolve 10 g of crude ursodeoxycholic acid with a purity of 90% in a mixed solution of acetone (60 mL) and ethanol (5 mL), stir and heat up to 60°C, add triethylamine (2.84g), and react at 65°C for 2h , and then the reaction solution was cooled, stirred at 0-5° C. for 1 h, filtered with suction, and the filter cake was washed with acetone (10 mL), dried in vacuo to obtain triethylammonium salt of ursodeoxycholic acid (9.5 g). Suspend the above triethylammonium salt of ursodeoxycholic acid in water (150mL), add 2mol/L aqueous sodium hydroxide solution, adjust the pH to 12.0, stir at 20-25°C for 1h; add 10% dilute Adjust the pH to 2.0 with hydrochloric acid, stir at 20-25°C for 1 h; filter, collect the filter cake, wash with water, and dry in vacuo to obtain 7.56 g of pure ursodeoxycholic acid, and the purification yield of ursodeoxycholic acid is 84%. The ursodeoxycholic acid purification yield of the method is lower than the embodiment of the method of the present invention.
对比例六Comparative example six
将专利文献CN 106928306A中的三乙胺替换为本发明提到的4-二甲氨基吡啶,其他步骤同专利文献CN106928306A,熊去氧胆酸产品纯化效率低于本发明的实施例。具体操作步骤如下:Replace the triethylamine in the patent document CN 106928306A with the 4-dimethylaminopyridine mentioned in the present invention, other steps are the same as the patent document CN106928306A, the purification efficiency of the ursodeoxycholic acid product is lower than the embodiment of the present invention. The specific operation steps are as follows:
(1)将10g 80%纯度的熊去氧胆酸粗品溶解于丙酮(60mL)和乙醇(5mL)的混合溶液中,搅拌升温至46℃,维持温度1.5h,加入DMAP(8.8mL),升温回流1.5h,降温至14℃,搅拌反应4h,过滤,用丙酮(10mL)洗涤滤饼,干燥,得到熊去氧胆酸的4-二甲基吡啶铵盐(9.21g)。(2)上述熊去氧胆酸的4-二甲基吡啶铵盐悬浮在水中(150mL),加入丙酮(100mL)和水(30mL),搅拌升温至46℃,维持温度0.5h,待完全溶解后,滴加冰乙酸调节PH值为4.7,加入5%质量的活性炭(0.5g)脱色2h,滤除活性炭,用丙酮(7mL)和水(3mL)的混合溶液洗涤活性炭,65℃以下常压蒸馏回收丙酮至残留液体70mL左右,停止回收,缓慢降温至10-15℃,搅拌1h,过滤,用水(10mL)洗涤滤饼,干燥得到熊去氧胆酸粗品;(3)将步骤(2)所得熊去氧胆酸加入3倍体积的乙酸乙酯,升温回流2h,缓慢降温至0-5℃,搅拌4h,过滤,干燥,得到熊去氧胆酸 6.87g,纯化收率为85.9%,此方法的熊去氧胆酸纯化收率低于本发明方法的实施例。(1) Dissolve 10g of crude ursodeoxycholic acid with 80% purity in a mixed solution of acetone (60mL) and ethanol (5mL), stir and heat up to 46°C, maintain the temperature for 1.5h, add DMAP (8.8mL), and heat up Reflux for 1.5 h, cool down to 14°C, stir for 4 h, filter, wash the filter cake with acetone (10 mL), and dry to obtain 4-lutidine ammonium salt of ursodeoxycholic acid (9.21 g). (2) Suspend the 4-lutidine ammonium salt of ursodeoxycholic acid in water (150mL), add acetone (100mL) and water (30mL), stir and raise the temperature to 46°C, maintain the temperature for 0.5h, and wait for complete dissolution Finally, add glacial acetic acid dropwise to adjust the pH value to 4.7, add 5% mass of activated carbon (0.5g) for decolorization for 2 hours, filter the activated carbon, wash the activated carbon with a mixed solution of acetone (7mL) and water (3mL), and store it under normal pressure below 65°C Distill and recover acetone until the residual liquid is about 70mL, stop the recovery, slowly cool down to 10-15°C, stir for 1h, filter, wash the filter cake with water (10mL), and dry to obtain the crude ursodeoxycholic acid; (3) Step (2) Add 3 times the volume of ethyl acetate to the obtained ursodeoxycholic acid, raise the temperature and reflux for 2 hours, slowly cool down to 0-5°C, stir for 4 hours, filter, and dry to obtain 6.87 g of ursodeoxycholic acid with a purification yield of 85.9%. The ursodeoxycholic acid purification yield of this method is lower than the embodiment of the method of the present invention.
对比例七Comparative example seven
将本发明专利中的丙酮用异丙醚替代,其他步骤同本发明实施例,结果发现所得熊去氧胆酸产品的纯度远低于本发明的实施例,不能实现本发明高收率得到纯度大于99%的熊去氧胆酸。具体操作步骤如下:The acetone in the patent of the present invention is replaced with isopropyl ether, and other steps are the same as the examples of the present invention. It is found that the purity of the obtained ursodeoxycholic acid product is far lower than that of the examples of the present invention, and the high yield of the present invention cannot be achieved to obtain the purity. Greater than 99% ursodeoxycholic acid. The specific operation steps are as follows:
将10g 90%纯度的熊去氧胆酸粗品溶解于异丙醚(60mL)和甲醇(5mL)的混合溶液中,搅拌升温至60℃,加入4-二甲氨基吡啶(3.2g),并在65℃下反应1.5h,然后将反应液冷却,在0-5℃下搅拌1h,抽滤,滤饼用异丙醚(10mL)洗涤,真空干燥,得到熊去氧胆酸的4-二甲基吡啶铵盐(11.3g)。上述熊去氧胆酸的4-二甲基吡啶铵盐悬浮在水中(150mL),加入2mol/L的氢氧化钠水溶液,将pH调节至12.0,在20-25℃下搅拌1h;滴加10%的稀盐酸调节pH至2.0,在20-25℃搅拌1h;过滤,收集滤饼并用水洗涤,真空干燥,得到熊去氧胆酸8.6g,液相纯度95%,此方法得到的熊去氧胆酸产品的纯度远低于本发明的实施例。10g of 90% pure ursodeoxycholic acid crude product was dissolved in a mixed solution of isopropyl ether (60mL) and methanol (5mL), stirred and warmed up to 60°C, added 4-dimethylaminopyridine (3.2g), and React at 65°C for 1.5h, then cool the reaction solution, stir at 0-5°C for 1h, filter with suction, wash the filter cake with isopropyl ether (10mL), and dry in vacuo to obtain 4-dimethyl ursodeoxycholic acid Pyridinium ammonium salt (11.3 g). Suspend the 4-dimethylpyridinium ammonium salt of ursodeoxycholic acid in water (150 mL), add 2 mol/L sodium hydroxide aqueous solution, adjust the pH to 12.0, stir at 20-25 °C for 1 h; add dropwise 10 % dilute hydrochloric acid to adjust the pH to 2.0, and stirred at 20-25°C for 1h; filtered, collected the filter cake and washed with water, and dried in vacuum to obtain 8.6g of ursodeoxycholic acid, with a liquid phase purity of 95%. The ursodeoxycholic acid obtained by this method The purity of oxycholic acid product is far lower than the embodiment of the present invention.
本发明通过4-二甲氨基吡啶处理熊去氧胆酸粗品,不仅操作方法简便,且熊去氧胆酸的纯化收率最高可达97.1%,产品纯度高(液相纯度>99%)。因此,本发明描述的熊去氧胆酸纯化方法更高效,更简便,更具有工业化价值。The present invention treats crude ursodeoxycholic acid by 4-dimethylaminopyridine, not only the operation method is simple, but also the purification yield of ursodeoxycholic acid can reach up to 97.1%, and the product has high purity (liquid phase purity>99%). Therefore, the purification method of ursodeoxycholic acid described in the present invention is more efficient, simpler and more industrially valuable.
本发明能够实现高效纯化熊去氧胆酸的关键技术是在特定的溶剂中,选定4-二甲氨基吡啶为碱,高收率得到熊去氧胆酸的4-二甲基吡啶铵盐,然后再经过酸解,高收率得到熊去氧胆酸纯品。The key technology of the present invention that can realize high-efficiency purification of ursodeoxycholic acid is to select 4-dimethylaminopyridine as the base in a specific solvent, and obtain 4-dimethylpyridinium ammonium salt of ursodeoxycholic acid in high yield , and then undergo acid hydrolysis to obtain pure ursodeoxycholic acid in high yield.
本发明的保护内容不局限于以上实施例。在不背离发明构思的精神和范围下,本领域技术人员能够想到的变化和优点都被包括在发明中,并且以所附的权利要求书为保护范围。The protection content of the present invention is not limited to the above embodiments. Without departing from the spirit and scope of the inventive concept, changes and advantages that can be imagined by those skilled in the art are all included in the invention, and the appended claims are the protection scope.
Claims (8)
- 一种熊去氧胆酸的纯化方法,其特征在于,所述方法包括以下步骤:A method for purifying ursodeoxycholic acid, characterized in that the method comprises the following steps:A.熊去氧胆酸的4-二甲基吡啶铵盐的制备A. Preparation of 4-lutidine ammonium salt of ursodeoxycholic acid将含有熊去氧胆酸的粗品溶于第一溶剂和第二溶剂的混合溶液中,搅拌升温至55-70℃,加入4-二甲氨基吡啶DMAP,升温回流反应1-4h,缓慢降温,在0-5℃条件下搅拌0.5-4h,抽滤,用第一溶剂洗涤滤饼,干燥,得到熊去氧胆酸的4-二甲基吡啶铵盐;Dissolve the crude product containing ursodeoxycholic acid in the mixed solution of the first solvent and the second solvent, stir and heat up to 55-70°C, add 4-dimethylaminopyridine DMAP, heat up and reflux for 1-4h, and slowly cool down, Stir at 0-5°C for 0.5-4h, filter with suction, wash the filter cake with the first solvent, and dry to obtain 4-dimethylpyridinium ammonium salt of ursodeoxycholic acid;B.熊去氧胆酸的4-二甲基吡啶铵盐的水解B. Hydrolysis of 4-lutidinium salt of ursodeoxycholic acid将所述步骤A中得到的熊去氧胆酸的4-二甲基吡啶铵盐悬浮在水中,加入碱调节pH至12.0-12.5,在20-25℃条件下搅拌1-4h;滴加酸调节pH至2.0-2.5,在20-25℃搅拌1-4h;过滤,收集滤饼并用水洗涤,干燥,得到熊去氧胆酸纯品;所述纯化方法的反应过程如路线(I)所示:Suspend the 4-lutidine ammonium salt of ursodeoxycholic acid obtained in step A in water, add alkali to adjust the pH to 12.0-12.5, stir at 20-25°C for 1-4h; add acid dropwise Adjust the pH to 2.0-2.5, stir at 20-25°C for 1-4h; filter, collect the filter cake, wash with water, and dry to obtain pure ursodeoxycholic acid; the reaction process of the purification method is as shown in route (I) Show:
- 根据权利要求1所述的熊去氧胆酸的纯化方法,其特征在于,步骤A中,所述第一溶剂为丙酮;所述第二溶剂选自四氢呋喃、甲醇、乙醇中的一种或多种。The method for purifying ursodeoxycholic acid according to claim 1, wherein in step A, the first solvent is acetone; the second solvent is selected from one or more of tetrahydrofuran, methanol, and ethanol kind.
- 根据权利要求1所述的熊去氧胆酸的纯化方法,其特征在于,步骤A中,所述4-二甲氨基吡啶的加入量是所述熊去氧胆酸粗品重量的0.31-0.47倍。The method for purifying ursodeoxycholic acid according to claim 1, wherein in step A, the amount of 4-dimethylaminopyridine added is 0.31-0.47 times the weight of the crude ursodeoxycholic acid .
- 根据权利要求1所述的熊去氧胆酸的纯化方法,其特征在于,所述加入的第一溶剂体积(毫升)数是熊去氧胆酸粗品重量(克)数的4-8倍;所述加入的第二溶剂体积(毫升)数是熊去氧胆酸粗品重量(克)数的0.3-1倍;所述洗涤滤饼的第一溶剂的体积(毫升)数是熊去氧胆酸粗品重量(克)数的1-3倍。The purification method of ursodeoxycholic acid according to claim 1, is characterized in that, the first solvent volume (milliliter) number that adds is 4-8 times of ursodeoxycholic acid crude product weight (gram) number; The second solvent volume (milliliter) number that adds is 0.3-1 times of ursodeoxycholic acid crude product weight (gram); The volume (milliliter) number of the first solvent of described washing filter cake is ursodeoxycholic acid 1-3 times the weight (grams) of crude acid.
- 根据权利要求1所述的熊去氧胆酸的纯化方法,其特征在于,步骤B中,所述熊去氧胆酸的4-二甲基吡啶铵盐悬浮使用的水的体积(毫升)数是熊去氧胆酸粗品重量(克)数的5-20倍。The purification method of ursodeoxycholic acid according to claim 1, is characterized in that, in step B, the volume (milliliter) of the water that the 4-lutidine ammonium salt of ursodeoxycholic acid is suspended uses It is 5-20 times the weight (grams) of crude ursodeoxycholic acid.
- 根据权利要求1所述的熊去氧胆酸的纯化方法,其特征在于,步骤B中,所述碱为氢氧化钠、氢氧化钾、氢氧化锂中的一种或几种。The method for purifying ursodeoxycholic acid according to claim 1, wherein in step B, the alkali is one or more of sodium hydroxide, potassium hydroxide, and lithium hydroxide.
- 根据权利要求1所述的熊去氧胆酸的纯化方法,其特征在于,步骤B中,所述酸为盐酸、 硫酸、磷酸、乙酸中的一种或几种。The method for purifying ursodeoxycholic acid according to claim 1, wherein in step B, the acid is one or more of hydrochloric acid, sulfuric acid, phosphoric acid, and acetic acid.
- 根据权利要求1所述的熊去氧胆酸的纯化方法,其特征在于,步骤B中,所述碱的浓度为1-8mol/L;所述酸的体积分数为10-90%;所述洗涤滤饼水的体积(毫升)数是熊去氧粗品重量(克)数的1-5倍。The purification method of ursodeoxycholic acid according to claim 1, characterized in that, in step B, the concentration of the alkali is 1-8mol/L; the volume fraction of the acid is 10-90%; the The volume (ml) of the water for washing the filter cake is 1-5 times the weight (gram) of the crude ursodeoxy product.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110779101.3A CN113480589B (en) | 2021-07-09 | 2021-07-09 | Purification method of ursodeoxycholic acid |
CN202110779101.3 | 2021-07-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023280313A1 true WO2023280313A1 (en) | 2023-01-12 |
Family
ID=77937798
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2022/104683 WO2023280313A1 (en) | 2021-07-09 | 2022-07-08 | Method for purifying ursodeoxycholic acid |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN113480589B (en) |
WO (1) | WO2023280313A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113480589B (en) * | 2021-07-09 | 2023-08-25 | 华东师范大学 | Purification method of ursodeoxycholic acid |
CN114315949A (en) * | 2022-01-19 | 2022-04-12 | 常德云港生物科技有限公司 | Purification method for removing 22-ene-UDCA impurity in ursodeoxycholic acid |
CN115716857A (en) * | 2022-10-28 | 2023-02-28 | 湖南科瑞生物制药股份有限公司 | Refining method of lithocholic acid |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001261696A (en) * | 2000-03-15 | 2001-09-26 | Mitsubishi-Tokyo Pharmaceuticals Inc | Tertiary amine salt of ursodeoxycholic acid and method for producing ursodeoxycholic acid using the same |
CN101215310A (en) * | 2008-01-10 | 2008-07-09 | 辽宁百隆生物工程有限公司 | Production method for producing ursodesoxycholic acid by using 98.0% of bovine and sheep cholic acid |
CN101987860A (en) * | 2009-08-06 | 2011-03-23 | 中山百灵生物技术有限公司 | Preparation method of ursodesoxycholic acid |
CN106928306A (en) * | 2017-03-15 | 2017-07-07 | 眉山市新功生物科技有限公司 | A kind of purification process of urso |
CN110669091A (en) * | 2019-10-18 | 2020-01-10 | 武汉大学 | Method for purifying ursodeoxycholic acid |
CN113480589A (en) * | 2021-07-09 | 2021-10-08 | 华东师范大学 | Purification method of ursodeoxycholic acid |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102911235A (en) * | 2011-08-01 | 2013-02-06 | 天津科技大学 | Method for producing ursodesoxycholic acid by using chenodeoxycholic acid as raw material |
CN109879923A (en) * | 2017-12-06 | 2019-06-14 | 陕西修风生物科技有限公司 | The separation purifying technique of high-purity natural ursodesoxycholic acid can be prepared |
-
2021
- 2021-07-09 CN CN202110779101.3A patent/CN113480589B/en active Active
-
2022
- 2022-07-08 WO PCT/CN2022/104683 patent/WO2023280313A1/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001261696A (en) * | 2000-03-15 | 2001-09-26 | Mitsubishi-Tokyo Pharmaceuticals Inc | Tertiary amine salt of ursodeoxycholic acid and method for producing ursodeoxycholic acid using the same |
CN101215310A (en) * | 2008-01-10 | 2008-07-09 | 辽宁百隆生物工程有限公司 | Production method for producing ursodesoxycholic acid by using 98.0% of bovine and sheep cholic acid |
CN101987860A (en) * | 2009-08-06 | 2011-03-23 | 中山百灵生物技术有限公司 | Preparation method of ursodesoxycholic acid |
CN106928306A (en) * | 2017-03-15 | 2017-07-07 | 眉山市新功生物科技有限公司 | A kind of purification process of urso |
CN110669091A (en) * | 2019-10-18 | 2020-01-10 | 武汉大学 | Method for purifying ursodeoxycholic acid |
CN113480589A (en) * | 2021-07-09 | 2021-10-08 | 华东师范大学 | Purification method of ursodeoxycholic acid |
Also Published As
Publication number | Publication date |
---|---|
CN113480589B (en) | 2023-08-25 |
CN113480589A (en) | 2021-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2023280313A1 (en) | Method for purifying ursodeoxycholic acid | |
CN102030798B (en) | Purification method of abiraterone acetate | |
CN106256824B (en) | Preparation method of high-purity delafloxacin meglumine salt | |
CN102766185B (en) | Method for respectively recovering ursodesoxycholic acid and chenodeoxycholic acid from ursodesoxycholic acid waste mother liquor | |
JP4892915B2 (en) | Epalrestat manufacturing method | |
CN109912676B (en) | Preparation method of 3 beta-ursodesoxycholic acid | |
CN112110971A (en) | Method for synthesizing progesterone | |
CN107312054A (en) | A kind of method that urso and Tauro ursodesoxy cholic acid are synthesized from pig's bile | |
CN116640088A (en) | Preparation method of high-purity Lei Fen narasin | |
CN113135973B (en) | Method for preparing ursodeoxycholic acid by using hyodeoxycholic acid | |
CN102911235A (en) | Method for producing ursodesoxycholic acid by using chenodeoxycholic acid as raw material | |
CN110669091A (en) | Method for purifying ursodeoxycholic acid | |
CN108383745B (en) | Preparation method of aceclofenac | |
WO2019129309A1 (en) | Preparation method for dexamethasone intermediate | |
JP6764998B2 (en) | How to make hydronidon | |
JP3810610B2 (en) | Tersamine amine salt of ursodeoxycholic acid and process for producing ursodeoxycholic acid using the same | |
CN104817546B (en) | Method for recovering olmesartan medoxomil mother liquor | |
CN112645889A (en) | Refining method of Favipiravir | |
JPS6254316B2 (en) | ||
CN106279333B (en) | A kind of hyodesoxycholic acid crystallization processes method of optimization | |
CN105503986A (en) | Prednisolone acetate preparation method | |
CN113666982A (en) | Purification method for synthesizing ursodeoxycholic acid based on biological enzyme method | |
CN114478682B (en) | Refining method of dexamethasone epoxy hydrolysate | |
CN104109185A (en) | Preparation method of abiraterone acetate | |
CN114031659B (en) | Preparation method of levonorgestrel impurity O |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22837058 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 22837058 Country of ref document: EP Kind code of ref document: A1 |